TACTILE SYSTEMS TECHNOLOGY INC

NASDAQ: TCMD (Tactile Systems Technology, Inc)

Last update: 1 hour ago

15.17

-0.03 (-0.20%)

Previous Close 15.20
Open 15.28
Volume 174,793
Avg. Volume (3M) 214,556
Market Cap 338,171,840
Price / Earnings (TTM) 24.47
Price / Earnings (Forward) 19.12
Price / Sales 1.12
Price / Book 1.60
52 Weeks Range
8.61 (-43%) — 21.10 (39%)
Earnings Date 3 Nov 2025
Profit Margin 5.52%
Operating Margin (TTM) -7.41%
Diluted EPS (TTM) 0.660
Quarterly Revenue Growth (YOY) 0.30%
Quarterly Earnings Growth (YOY) 18.50%
Total Debt/Equity (MRQ) 21.23%
Current Ratio (MRQ) 4.52
Operating Cash Flow (TTM) 40.15 M
Levered Free Cash Flow (TTM) 30.02 M
Return on Assets (TTM) 4.66%
Return on Equity (TTM) 8.12%

Market Trend

Short Term Medium Term
Industry Medical Devices (US) Mixed Bearish
Medical Devices (Global) Mixed Bearish
Stock Tactile Systems Technology, Inc Bullish Bullish

AIStockmoo Score

0.9
Analyst Consensus 1.5
Insider Activity NA
Price Volatility -2.0
Technical Moving Averages 0.0
Technical Oscillators 4.0
Average 0.88

Similar Stocks

Stock Market Cap DY P/E (TTM) P/B
TCMD 338 M - 24.47 1.60
MASI 8 B - - 7.37
BRKR 5 B 0.64% 60.46 2.93
LIVN 3 B - - 2.49
NVCR 2 B - - 4.50
ATEC 1 B - - 85.66

Tactile Systems Technology Inc is a medical technology company. The company is engaged in developing and providing medical devices for the treatment of chronic diseases. The firm's proprietary platform flexitouch system provides a home-based solution for lymphedema patients. The entire system is another home solution for patients with chronic swelling and actitouch system for chronic venous insufficiency patients that may be worn throughout the day.

Sector Healthcare
Industry Medical Devices
Investment Style Small Core
% Held by Insiders 2.67%
% Held by Institutions 100.51%

Ownership

Name Date Shares Held
Cadian Capital Management, Lp 30 Jun 2025 2,309,616
Capitolis Liquid Global Markets Llc 30 Jun 2025 902,062
Deutsche Bank Ag\ 30 Jun 2025 618,887
Polar Asset Management Partners Inc. 30 Jun 2025 392,107
Invenomic Capital Management Lp 30 Jun 2025 371,887
52 Weeks Range
8.61 (-43%) — 21.10 (39%)
Price Target Range
13.00 (-14%) — 23.50 (54%)
High 23.50 (Lake Street, 54.91%) Buy
Median 18.25 (20.30%)
Low 13.00 (B. Riley Securities, -14.31%) Hold
Average 18.25 (20.30%)
Total 1 Buy, 1 Hold
Avg. Price @ Call 13.87
Firm Date Target Price Call Price @ Call
Lake Street 03 Oct 2025 23.50 (54.91%) Buy 15.20
B. Riley Securities 05 Aug 2025 13.00 (-14.30%) Hold 12.54

No data within this time range.

The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.

Portfolio

AI Template

Your price alert

Risk Profile

| | | | |
Conservative
Moderate Conservative
Moderate
Moderate Aggressive
Aggressive
Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)

Disclaimer: The above is for illustrative purposes only and is NOT investment advice. Seek advice from a qualified financial professional.

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

52W Range
 
52WL
 
52WH
SL
EP
TP1
TP2

All alert prices are within 52 weeks price range

Realized Profit -
Unrealized Profit -
Dividend Received 2025 -
Total Profit -
Avg. Return -
Quantity (Buy) -
Avg. Price (Buy) -
Quantity (Sold) -
Avg. Price (Sold) -
No stocks matching your criteria